Ulsaven en es it fr

Ulsaven Brand names, Ulsaven Analogs

Ulsaven Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ulsaven Chemical_Formula


Ulsaven RX_link


Ulsaven fda sheet

Ulsaven FDA

Ulsaven msds (material safety sheet)

Ulsaven MSDS

Ulsaven Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ulsaven Molecular Weight

314.405 g/mol

Ulsaven Melting Point

69-70 oC

Ulsaven H2O Solubility

24.7 mg/mL

Ulsaven State


Ulsaven LogP


Ulsaven Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ulsaven Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ulsaven Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ulsaven Absorption

Approximately 50% bioavailability orally.

Ulsaven side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ulsaven Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ulsaven Organisms Affected

Humans and other mammals